| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.3 | 0.05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |